VI
EBACW

Vestcor Inc’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Vestcor Inc’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,666
Closed -$3K – 1351
2022
Q4 		$3K Hold
11,666
– – ﹤0.01% 1219
2022
Q3 		$1K Hold
11,666
– – ﹤0.01% 1345
2022
Q2 		$1K Hold
11,666
– – ﹤0.01% 1338
2022
Q1 		$2K Hold
11,666
– – ﹤0.01% 1406
2021
Q4 		$7K Hold
11,666
– – ﹤0.01% 1366
2021
Q3 		$7K Hold
11,666
– – ﹤0.01% 1256
2021
Q2 		$11K Buy
+11,666
New +$10.9K ﹤0.01% 1257

Vestcor Inc's EBACW Position: Q1 2023 in Review

Vestcor Inc sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 11,666 shares — an estimated $3K sold.

Vestcor Inc first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $11K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • Vestcor Inc reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Vestcor Inc sold 11,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $3K.
  • Vestcor Inc first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
  • Vestcor Inc's European Biotech Acquisition Corp. Warrant position peaked at $11K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Vestcor Inc's 13F filing for Q1 2023, filed 15 May 2023.